Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome

Arthritis Research and Therapy

Volumn 11, Issue 5, 2009, Pages

  Raterman, Hennie G ^a   Voskuyl, Alexandre E ^a   Dijkmans, Ben A C ^a,b   Nurmohamed, Michael T ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JAN VAN BREEMEN INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CREATININE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FOLIC ACID; GLUCOSE; HOMOCYSTEINE; LIPID; METHOTREXATE; ANTIRHEUMATIC AGENT;

BODY MASS; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG EFFECT; GLUCOSE METABOLISM; GROUPS BY AGE; HEALTH STATUS; HUMAN; HYPOTHYROIDISM; LETTER; LIPID METABOLISM; METABOLIC SYNDROME X; PULSE RATE; RHEUMATOID ARTHRITIS; SENESCENCE; NOTE; PREVALENCE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; METABOLIC SYNDROME X; METHOTREXATE; PREVALENCE;

EID: 75649095701     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2805     Document Type: Letter

References (2)

1. Toms TE, Panoulas VF, Douglas KMJ, Kitas GD. Methotrexate therapy associates with a reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60: more than just an anti-inflammatory effect? A cross-sectional study. Arthritis Res Ther 2009, 11:R110. 10.1186/ar2765, 2745792, 19607680.
2. Raterman HG, van Eijk IC, Voskuyl AE, Peters MJ, Dijkmans BA, van Halm VP, Simsek S, Lems WF, Nurmohamed MT. The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study. Ann Rheum Dis 2008,